Management ChangeJul 27, 2026, 04:16 PM
Kymera Therapeutics Appoints Dr. Terence Rooney as New CMO
AI Summary
Kymera Therapeutics, Inc. announced the retirement of Dr. Jared Gollob as Chief Medical Officer, effective July 27, 2026. Dr. Gollob will transition to an advisory role until the end of the year. Concurrently, Dr. Terence Rooney has been appointed as the new CMO, bringing extensive experience in immunology drug development from his previous role at Johnson & Johnson.
Key Highlights
- Dr. Jared Gollob retired as Chief Medical Officer (CMO) of Kymera Therapeutics on July 27, 2026.
- Dr. Gollob will continue to serve as an advisor to the Company until December 31, 2026.
- Dr. Terence Rooney was appointed as the new CMO, effective July 27, 2026.
- Dr. Rooney previously served as Senior Vice President, Portfolio and Asset Management Leader, Immunology, at Johnson & Johnson.
- Dr. Rooney has extensive experience in advancing immunology therapies from early clinical stages through commercialization.
Price Impact
More from KYMR